Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NEJM Study Touts Longer Lasting Survival Benefit Of Endovascular AAA Repair

This article was originally published in The Gray Sheet

Executive Summary

The relative long-term benefits of endovascular repair versus invasive surgery for abdominal aortic aneurysms (AAA) may be greater than previously thought, according a study published Jan. 31 in the New England Journal of Medicine

You may also be interested in...



U.K. Studies: No Lasting Mortality Benefit For Endovascular AAA Repair

Results of two United Kingdom-based studies of abdominal aortic aneurysm repair conclude endovascular stent grafts are not associated with lower long-term mortality and death rates compared with surgical repair or no intervention

U.K. Studies: No Lasting Mortality Benefit For Endovascular AAA Repair

Results of two United Kingdom-based studies of abdominal aortic aneurysm repair conclude endovascular stent grafts are not associated with lower long-term mortality and death rates compared with surgical repair or no intervention

U.K. Agency Backs Endovascular Repair For Unruptured Aortic Aneurysms

The U.K. National Institute for Health and Clinical Excellence supports the option of using endovascular stent grafts to repair unruptured abdominal aortic aneurysms in place of invasive surgery, but cautions physicians to take into account such factors as patient fitness for surgery before settling on treatment method

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025734

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel